Reference-Less OECT Biosensor for Miniaturized Aptamer Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing electrochemical aptamer-based (E-AB) sensors face challenges in miniaturization due to small signals and reliance on reference electrodes, which are bulky and toxic, limiting their application in implantable biosensing.

Innovation Solution

A reference-less organic electrochemical transistor (OECT) biosensor with a monolayer of aptamers is used, where the binding of target small molecules generates an electrochemical signal that amplifies current through the channel, allowing for miniaturization without signal loss, and utilizes a voltage pulse to determine the proportion of bound aptamers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Volume of moving object

If E-AB sensors are miniaturized to reduce size for implantable use, then the sensor becomes more suitable for implantation, but the signal strength diminishes due to limited current from fewer aptamers

Engineering Contradiction:
Improvesensor sizeVSAvoidsignal strength
Core Design Contradiction:
Volume of moving objectVSReliability

Solution Approach 1:

The patent combines the transduction function (converting biochemical binding events into electrical signals) and amplification function (boosting signal strength) into a single integrated OECT device. The aptamers are immobilized on the gate electrode of the OECT, which simultaneously detects the binding event through electrochemical signal generation and amplifies it through ion-to-electron transduction in the channel, eliminating the need for separate amplification components and enabling miniaturization without signal loss

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The OECT changes the transduction mechanism parameter from direct electrochemical current measurement to ion-to-electron transduction with current amplification. By utilizing the OECT's ability to convert ionic current changes at the gate into amplified electronic current at the drain, the system achieves high signal output even with minimal aptamer binding events, allowing sensor miniaturization while maintaining reliability

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If a reference electrode is included in E-AB sensors for accurate measurement, then measurement accuracy is improved, but device complexity and size increase

Engineering Contradiction:
Improvemeasurement accuracyVSAvoidsensor structure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the reference electrode component from the sensor system by utilizing the OECT's intrinsic ability to provide stable electrochemical measurements. The OECT's gate electrode serves as the working electrode while the source and drain electrodes provide stable reference potentials through their fixed voltage biasing, removing the need for a separate reference electrode and simplifying the overall device structure

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The OECT structure performs multiple functions simultaneously: the gate electrode acts as the sensing electrode for aptamer binding detection, while the source and drain electrodes provide both current path and stable electrical reference. This multi-functionality eliminates the need for dedicated reference electrode components, reducing device complexity while maintaining measurement precision

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of operation

If common pseudo-reference electrode materials are used in E-AB sensors, then initial measurement is possible, but potential shift and toxicity occur with prolonged sensing application

Engineering Contradiction:
Improveinitial measurement capabilityVSAvoidtissue toxicity and potential shift
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent employs biocompatible organic materials for the OECT channel and electrodes that are inherently safe for prolonged in vivo contact. These materials replace traditional metal pseudo-reference electrodes that suffer from toxicity and potential drift over time. The organic electrochemical transistor uses materials like PEDOT:PSS or other biocompatible conducting polymers that are non-toxic and stable for continuous sensing applications, eliminating the harmful effects of conventional reference electrode materials

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The OECT biosensor achieves scalable signal amplification, maintaining output signals even with miniaturization, and is biocompatible for implantable use, providing continuous and selective detection of small molecules.

Implementation Method 1

a second end functionalized with a redox reporter molecule, the binding of a target small molecule to an aptamer generating an electrochemical signal

Methodology Applied
Scientific EffectRedox reactions: Redox Reactions

Implementation Method 2

generates an electrochemical signal that in turn generates an amplified current through the channel of the OECT

Methodology Applied
Scientific EffectIon-to-electron transduction and current amplification:

Data Source

PatentUS12449393B2Transistor-based biosensor
Publication Date: 2025.10.21 ELECTRADX INC
  • US12449393B2 patent drawing
  • US12449393B2 patent drawing
  • US12449393B2 patent drawing

AI summary

Broadly speaking, embodiments of the present techniques generally provide biosensors for detecting target small molecules in a fluid sample. In particular, the present techniques provide a biosensor comprising an organic electrochemical transistor, OECT and a monolayer of aptamers designed to bind to a target small molecule. The biosensor may be of a size to make it suitable for wearing on or implanting in a human or animal body.